An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous inflixim...
Published in Clinical rheumatology
This prospective open-label pilot study evaluated the effectiveness and safety of adalimumab and the relationship to antibodies against infliximab (IFX) in adult patients with active rheumatoid arthritis (RA) who had been treated previously with IFX and experienced treatment failure owing to lack or loss of response or intolerance. Patients self-ad...
